The new group was instigated by ten international experts who met at the Novartis Foundation in London last month to discuss recent evidence that a common viral infection may be triggering the disease and the possibility of developing a vaccine to protect individuals at risk.
“This area of diabetes research has been neglected for far too long,” says Professor Keith Taylor, of the Centre for Diabetes and Metaboloic Medicine at Barts and The London. “It is essential to follow up today’s very promising lines of research if we hope to cut the increasing burden of this disease in childhood.” These thoughts were echoed by other meeting participants, including Professor Abner Notkins of the National Institutes of Health, Washington, USA.
Type1 diabetes currently affects several million children worldwide and its incidence is rising steadily. The VIDIS Group aims to foster collaboration between research workers and look for common ways forward. “If a virus is involved, then vaccination as a preventive measure is a realistic possibility,” adds Professor Taylor.
The nature of the triggering agent in children with diabetes has long been debated. Studies in the 1960s first suggested that, the start of the disease was often associated with the coxsackie virus, a common childhood infection.
Recent epidemiological studies from Finnish scientists suggest that diabetic children are infected with these viruses long before the disease is diagnosed. And researchers in Scotland, Italy and Finland have detected coxsackie viruses in the pancreas of diabetic children at post mortem, confirming an early report.
It is now over 80 years since insulin was discovered. Although it has made the lives of people with type I diabetes possible, insulin cannot prevent its disabling complications. “We need to know what destroys the insulin-producing cells in the first place. This is why those of us gathered in London felt that our work on viruses should be extended – with urgency,” says Professor Taylor.
Professor Keith Taylor | alfa
Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University
Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
15.11.2018 | Earth Sciences
15.11.2018 | Physics and Astronomy
15.11.2018 | Physics and Astronomy